Correlates of delayed disease progression in HIV-1-infected Kenyan children. 2005

Rana Chakraborty, and Anne-Sophie Morel, and Julian K Sutton, and Victor Appay, and Ruth M Ripley, and Tao Dong, and Tim Rostron, and Simon Ogola, and Tresa Palakudy, and Rachel Musoke, and Angelo D'Agostino, and Mary Ritter, and Sarah L Rowland-Jones
Pediatric Infectious Diseases Unit, St. George's Hospital, London, United Kingdom. rchakrab@sghms.ac.uk

Without treatment most HIV-1-infected children in Africa die before their third birthday (>89%) and long-term nonprogressors are rare. The mechanisms underlying nonprogression in HIV-1-infected children are not well understood. In the present study, we examined potential correlates of delayed HIV disease progression in 51 HIV-1-infected African children. Children were assigned to progression subgroups based on clinical characterization. HIV-1-specific immune responses were studied using a combination of ELISPOT assays, tetramer staining, and FACS analysis to characterize the magnitude, specificity, and functional phenotype of HIV-1-specific CD8(+) and CD4(+) T cells. Host genetic factors were examined by genotyping with sequence-specific primers. HIV-1 nef gene sequences from infecting isolates from the children were examined for potential attenuating deletions. Thymic output was measured by T cell rearrangement excision circle assays. HIV-1-specific CD8(+) T cell responses were detected in all progression groups. The most striking attribute of long-term survivor nonprogressors was the detection of HIV-1-specific CD4(+) Th responses in this group at a magnitude substantially greater than previously observed in adult long-term nonprogressors. Although long-term survivor nonprogressors had a significantly higher percentage of CD45RA(+)CD4(+) T cells, nonprogression was not associated with higher thymic output. No protective genotypes for known coreceptor polymorphisms or large sequence deletions in the nef gene associated with delayed disease progression were identified. In the absence of host genotypes and attenuating mutations in HIV-1 nef, long-term surviving children generated strong CD4(+) T cell responses to HIV-1. As HIV-1-specific helper cells support anti-HIV-1 effector responses in active disease, their presence may be important in delaying disease progression.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007630 Kenya A republic in eastern Africa, south of ETHIOPIA, west of SOMALIA with TANZANIA to its south, and coastline on the Indian Ocean. Its capital is Nairobi. Republic of Kenya
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph

Related Publications

Rana Chakraborty, and Anne-Sophie Morel, and Julian K Sutton, and Victor Appay, and Ruth M Ripley, and Tao Dong, and Tim Rostron, and Simon Ogola, and Tresa Palakudy, and Rachel Musoke, and Angelo D'Agostino, and Mary Ritter, and Sarah L Rowland-Jones
March 2010, PLoS neglected tropical diseases,
Rana Chakraborty, and Anne-Sophie Morel, and Julian K Sutton, and Victor Appay, and Ruth M Ripley, and Tao Dong, and Tim Rostron, and Simon Ogola, and Tresa Palakudy, and Rachel Musoke, and Angelo D'Agostino, and Mary Ritter, and Sarah L Rowland-Jones
January 2015, PloS one,
Rana Chakraborty, and Anne-Sophie Morel, and Julian K Sutton, and Victor Appay, and Ruth M Ripley, and Tao Dong, and Tim Rostron, and Simon Ogola, and Tresa Palakudy, and Rachel Musoke, and Angelo D'Agostino, and Mary Ritter, and Sarah L Rowland-Jones
February 1997, The Journal of experimental medicine,
Rana Chakraborty, and Anne-Sophie Morel, and Julian K Sutton, and Victor Appay, and Ruth M Ripley, and Tao Dong, and Tim Rostron, and Simon Ogola, and Tresa Palakudy, and Rachel Musoke, and Angelo D'Agostino, and Mary Ritter, and Sarah L Rowland-Jones
May 2016, Medicine,
Rana Chakraborty, and Anne-Sophie Morel, and Julian K Sutton, and Victor Appay, and Ruth M Ripley, and Tao Dong, and Tim Rostron, and Simon Ogola, and Tresa Palakudy, and Rachel Musoke, and Angelo D'Agostino, and Mary Ritter, and Sarah L Rowland-Jones
September 1994, The Journal of infection,
Rana Chakraborty, and Anne-Sophie Morel, and Julian K Sutton, and Victor Appay, and Ruth M Ripley, and Tao Dong, and Tim Rostron, and Simon Ogola, and Tresa Palakudy, and Rachel Musoke, and Angelo D'Agostino, and Mary Ritter, and Sarah L Rowland-Jones
March 2007, AIDS (London, England),
Rana Chakraborty, and Anne-Sophie Morel, and Julian K Sutton, and Victor Appay, and Ruth M Ripley, and Tao Dong, and Tim Rostron, and Simon Ogola, and Tresa Palakudy, and Rachel Musoke, and Angelo D'Agostino, and Mary Ritter, and Sarah L Rowland-Jones
December 2012, Journal of acquired immune deficiency syndromes (1999),
Rana Chakraborty, and Anne-Sophie Morel, and Julian K Sutton, and Victor Appay, and Ruth M Ripley, and Tao Dong, and Tim Rostron, and Simon Ogola, and Tresa Palakudy, and Rachel Musoke, and Angelo D'Agostino, and Mary Ritter, and Sarah L Rowland-Jones
March 2012, AIDS (London, England),
Rana Chakraborty, and Anne-Sophie Morel, and Julian K Sutton, and Victor Appay, and Ruth M Ripley, and Tao Dong, and Tim Rostron, and Simon Ogola, and Tresa Palakudy, and Rachel Musoke, and Angelo D'Agostino, and Mary Ritter, and Sarah L Rowland-Jones
July 2007, Journal of acquired immune deficiency syndromes (1999),
Rana Chakraborty, and Anne-Sophie Morel, and Julian K Sutton, and Victor Appay, and Ruth M Ripley, and Tao Dong, and Tim Rostron, and Simon Ogola, and Tresa Palakudy, and Rachel Musoke, and Angelo D'Agostino, and Mary Ritter, and Sarah L Rowland-Jones
January 2019, Frontiers in immunology,
Copied contents to your clipboard!